Amgen CDR Valuation
| AMGN Stock | 28.58 0.73 2.62% |
At this time, the firm appears to be overvalued. Amgen CDR shows a prevailing Real Value of USD27.33 per share. The current price of the firm is USD28.58. Our model approximates the value of Amgen CDR from analyzing the firm fundamentals such as return on equity of 81.71, and Net Income of 4.09 B as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Amgen CDR's price fluctuation is very steady at this time. Calculation of the real value of Amgen CDR is based on 3 months time horizon. Increasing Amgen CDR's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Amgen CDR is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Amgen Stock. However, Amgen CDR's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 28.58 | Real 27.33 | Hype 28.41 | Naive 29.59 |
The intrinsic value of Amgen CDR's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Amgen CDR's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Amgen CDR helps investors to forecast how Amgen stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Amgen CDR more accurately as focusing exclusively on Amgen CDR's fundamentals will not take into account other important factors: About Amgen CDR Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Amgen CDR. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Amgen CDR based exclusively on its fundamental and basic technical indicators. By analyzing Amgen CDR's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Amgen CDR's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Amgen CDR. We calculate exposure to Amgen CDR's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Amgen CDR's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 30.3 B | 25.6 B |
Other Information on Investing in Amgen Stock
Amgen CDR financial ratios help investors to determine whether Amgen Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Amgen with respect to the benefits of owning Amgen CDR security.